Dr Emanuela Costigliola joins Newcells Biotech’s executive team as a Chief Marketing Officer

Emanuela’s extensive career brings a wealth of experience in marketing in the life science and biotechnology industry and a track record of senior leadership roles at some of the leading players including, GE Healthcare, Qiagen, Life Technologies and most recently as Head of Marketing and Communications at the Cell and Gene Therapy Catapult. An advocate for sales and launch excellence, holding a PhD in Immunology and Molecular Pathology, she was the Global Capability Director in Immuno-oncology for AstraZeneca and has consulted and developed commercial capabilities for key players in the field.

“I am delighted to welcome Emanuela to the Newcells executive team. Her experience will support our strategic growth plans to make sure we continue to address the market’s need and progress the field through our innovative technology.” Dr Mike Nicholds, CEO

About Newcells Biotech Ltd Newcells Biotech, a leading provider of in vitro tissue models, improves clinical translation and drug discovery enabling companies to progress their products into first in man. Combining expert know-how and extensive bioprocessing capabilities, Newcells‘ strength lies in the generation of predictive human in vitro data. Their unique approach enables a deeper understanding of how new drugs interact with specific tissues and provide key mechanistic insights relating to safety and efficacy of new therapeutic compounds. Based in Newcastle upon Tyne, Newcells Biotech offers an extensive range of products and services which are distributed worldwide. For more information, please visit the Newcells Biotech website at https://newcellsbiotech.co.uk/